Aquilo Capital Management as of Sept. 30, 2018
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 12 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 44.1 | $106M | 1.1M | 95.87 | |
| Merus N V (MRUS) | 10.7 | $26M | 1.3M | 19.74 | |
| Loxo Oncology | 7.8 | $19M | 109k | 170.83 | |
| Fate Therapeutics (FATE) | 6.7 | $16M | 985k | 16.29 | |
| Aduro Biotech | 6.5 | $16M | 2.1M | 7.35 | |
| Synlogic | 5.9 | $14M | 998k | 14.21 | |
| Cytomx Therapeutics (CTMX) | 5.2 | $13M | 675k | 18.50 | |
| Pieris Pharmaceuticals | 4.6 | $11M | 2.0M | 5.60 | |
| Spero Therapeutics (SPRO) | 3.5 | $8.4M | 800k | 10.51 | |
| Xenon Pharmaceuticals (XENE) | 3.3 | $7.8M | 593k | 13.20 | |
| Galapagos Nv- (GLPG) | 1.5 | $3.5M | 31k | 112.42 | |
| Morphosys (MOR) | 0.1 | $243k | 9.1k | 26.74 |
